The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $80.21

Today's change-1.38 -1.69%
Updated January 20 4:00 PM EST. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $80.21

Today's change-1.38 -1.69%
Updated January 20 4:00 PM EST. Delayed by at least 15 minutes.

DexCom Inc down (U.S.)$1.38

DexCom Inc closed sharply lower Friday, dropping (U.S.)$1.38 or 1.69% to (U.S.)$80.21. Shares have lost 5.78% for the last five days, but have gained 8.33% over the last 52 weeks. This security has underperformed the S&P 500 by 13.82% during the last year.

Key company metrics

  • Open(U.S.) $81.60
  • Previous close(U.S.) $81.59
  • High(U.S.) $82.26
  • Low(U.S.) $79.63
  • Bid / Ask(U.S.) $79.51 / (U.S.) $84.03
  • YTD % change+34.36%
  • Volume1,225,074
  • Average volume (10-day)2,417,207
  • Average volume (1-month)1,682,889
  • Average volume (3-month)1,370,084
  • 52-week range(U.S.) $47.92 to (U.S.) $96.38
  • Beta0.43
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.68
Updated January 20 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.90%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue149137116131
Total other revenue--------
Total revenue149137116131
Gross profit101867591
Total cost of revenue48524140
Total operating expense167157135129
Selling / general / administrative76696261
Research & development44363229
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-19-20-192
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-19-20-192
Income after tax-19-20-192
Income tax, total00--0
Net income-19-20-192
Total adjustments to net income--------
Net income before extra. items-19-20-192
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-19-20-192
Inc. avail. to common incl. extra. items-19-20-192
Diluted net income-19-20-192
Dilution adjustment------0
Diluted weighted average shares84848282
Diluted EPS excluding extraordinary itemsvalue per share-0.22-0.24-0.230.02
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.22-0.24-0.230.02